Prostate Cancer
Clinical Trials
2) Cohort 21 and 23 part of XL184-021 EXELIXIS: A Phase Ib Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Advanced or Metastatic Solid Tumors (More information under Prostate Cancer/Solid Tumors Section)
Send UsA Message
The Power of a United Breast Cancer Team: Your Leading Breast Cancer Allies
From diagnosis to treatment and follow-ups, Charleston Oncology, as a part of the Department of Bon Secours St. Francis’ leading multidisciplinary cancer care team, plays a vital role in guiding patients through their breast cancer journey.
Celebrating Strength and Hope: Join Us for the 6th Annual Pink Promenade
Celebrating Strength and Hope: Join Us for the 6th Annual Pink Promenade Mount Pleasant Towne Centre is thrilled to announce our 6th Annual Pink Promenade Breast Cancer Awareness Fundraiser, an event that embodies hope, strength, and resilience. Scheduled for...
Jenny’s Journey Reflects Our Mission
At Charleston Oncology, the mission of healing all people with compassion, faith and excellence resonates through the hallways and translates into every patient interaction.
Myra Walks in a Patient’s Shoes
In the busy corridors of Charleston Oncology on a triple-booked day of patients, a moment of pure human kindness unfolded, illustrating what it truly means to walk in a patient’s shoes.
March is National Colorectal Cancer Awareness Month
March is Colorectal Cancer Awareness Month. This month, Charleston Oncology recognizes the importance of spreading awareness surrounding the disease.
Empowering Health: Charleston Oncology Observes National Cancer Prevention Month
Empowering Health: Charleston Oncology Observes National Cancer Prevention Month Every year in the United States, nearly 1.9 million people (about twice the population of South Dakota) face the life-altering diagnosis of cancer, according to the National Institutes of...